cancer treated with mastectomy, adjuvant chemotherapy, radiotherapy, and 5 years of endocrine therapy. Seven years after the initial diagnosis and approximately two years after completion of endocrine therapy, she…
widely employed in breast cancer treatment. However, its clinical effectiveness is limited by nonspecific tissue distribution, dose-dependent cardiotoxicity, rapid systemic elimination, and the development of multidrug…
most intractable cancers with a poor prognosis. Because current treatments are associated with problems such as adverse effects and therapeutic resistance, the development of new, highly selective therapeutic approaches…
cognitive development. Game-Based Learning (GBL), particularly puzzle-based approaches, offers a promising strategy to promote active learning and clinical application of biochemical and physiological concepts relevant…
breast cancer. Endocrine therapy combined with cyclin dependent kinase 4 and 6 (CDK4/6) inhibitors is standard for advanced disease; however, resistance often develops, frequently driven by estrogen receptor ... cancer…
worldwide as recorded in 2020. In India, the incidence of endometrial cancer is very low as compared to developed countries with a reported incidence of 16,413 cases ... during hormone replacement therapy has been…
Nanobiomaterials are transforming regenerative medicine by enabling the development of highly sensitive diagnostic plat forms and advanced tissue engineering strategies. This presentation explores recent advances in…
using technique immunohistochemistry (IHC); we can categorize Triple negative breast cancer (TNBC) as a diverse disease negative for receptors like human epidermal growth factor receptor 2 (HER2); progesterone receptor…
promising platform for targeted and controlled cancer therapy, with strong potential to improve treatment efficacy, reduce toxicity, and support the future development of precision oncology
targeted therapeutic strategies that bridge the gap between laboratory discoveries and clinical practice. Key developments include biologic therapies targeting specific inflammatory pathways, Janus kinase (JAK)…
prospective study enrolled 210 adult oncology patients receiving anthracycline-based chemotherapy at a tertiary cancer center. Comprehensive echocardiographic assessments, including conventional two-dimensional…
walled rectal phantom and an epoxy-walled, water-filled bladder phantom — against 50 cervical cancer patients. Materials and Methods: CT-derived mean Hounsfield unit (HU), electron density (ED), and volume ... material…
that strengthens dough and increases bread volume. However, the International Agency for Research on Cancer (IARC) has labeled it as a possible human carcinogen. Despite being banned in many countries ... Ethiopia…
Accumulating evidence supports the involvement of PRMT5 in cancer development; however, its cross-cancer molecular features remain incompletely characterized. Here, we performed an integrated pan-cancer analysis of PRMT5
effects against metastatic breast cancer. However, its clinical efficacy is often limited by poor aqueous solubility and systemic toxicity. The present study aims to develop and evaluate Eribulin-loaded cubosomes…
signaling. In vitro studies show inhibition of proliferation and induction of apoptosis across multiple cancer cell lines, while in vivo models report reduced tumor growth, enhanced antioxidant enzyme activity…
Background: Exposure to ultraviolet (UV) radiation poses significant health risks, including skin cancer, premature aging, and ocular damage. Sunscreen use is one of the most effective preventive strategies against…
single-center cohort. Methods: This retrospective observational study included 54 patients diagnosed with bladder cancer and treated at the Clinic of Urology, Prishtina, between January 2000 and March 2026. Demographic…
global warming occurring across the world. Anticancer drugs either completely kill most cancer cells or, in some ways, modify their growth. However, the selectivity of most medications is constrained, which ... drugs…
recurrence rates, managing them is still difficult. The development, progression, and treatment resistance of gliomas have all been linked to Cancer Stem Cells (CSCs). A well-known CSC marker, CD133
developed countries, the stigma attached to terminal illness diminished in the 20th century. However, the Indian attitude towards mental health issues associated with cancer is still a longstanding stigma ... specifies…
across databases including PubMed, PsycINFO, CINAHL, and Scopus for qualitative studies addressing pediatric terminal cancer and palliative care. Studies were analyzed to identify recurring themes and patterns in the…
activity, with IC50 values of 33.54±2.2 µM and 36.60±2.4 µM in Michigan cancer foundation-7 cells ... lead molecules for further mechanistic investigations and optimisation studies aimed at developing new therapeutic…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.